Filgotinib maintained a favorable safety and efficacy profile for up to 8 years among patients with RA who participated in the DARWIN 3 LTE.

In a US study, researchers found that 35% of adults with IBD screened positive for spondyloarthritis, despite having no known SpA diagnosis.

GLP-1 receptor agonists are not associated with an increased risk for suicidality compared with DPP-4 inhibitors or SGLT-2 inhibitors.

Emapalumab-Izsg is under the FDA’s Priority Review for hemophagocytic lymphohistiocytosis/macrophage activation syndrome in Still disease.

Chronic diseases misdiagnosed as psychosomatic can lead to long-term damage to patients' physical and mental well-being.

Higher adherence to the Mediterranean diet is associated with a modest reduction in the risk for obesity-related cancers.

A presidential advisory has been published by the AHA regarding US government funding for the National Institutes of Health.

A recent study finds that nonmalignant gynecological diseases are associated with cardiovascular and/or cerebrovascular disease.

For patients with moderate-to-severe plaque psoriasis, ixekizumab is effective and safe, with induction therapy enhancing initial response.

Mortality rates among US adults spiked from 2011 to 2019 and 2020 to 2023, remaining higher than expected based on prepandemic levels.

Frailty is increasingly being viewed as an emerging risk factor for poor outcomes among patients with autoimmune or rheumatic ...

Patients with rheumatoid arthritis who use biological DMARDs are unlikely to achieve sustained DMARD-free remission.